ResearcherUniversity of Wisconsin–MadisonNo recent work listed

Weiyu Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4436-2743; OpenAlex author ID A5100373308. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. Co-author DOI 10.1007/s00259-021-05563-1 ↗
ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00259-021-05216-3 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Miao Li · 2 shared papers, 2021–2022 · strength 0.28
- Paper ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. DOI 10.1007/s00259-021-05563-1 ↗
- Paper ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma. DOI 10.1007/s00259-021-05216-3 ↗
Dawei Jiang · 2 shared papers, 2021–2022 · strength 0.28
- Paper ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. DOI 10.1007/s00259-021-05563-1 ↗
- Paper ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma. DOI 10.1007/s00259-021-05216-3 ↗
Weibo Cai · 2 shared papers, 2021–2022 · strength 0.28
- Paper ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. DOI 10.1007/s00259-021-05563-1 ↗
- Paper ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma. DOI 10.1007/s00259-021-05216-3 ↗
Min Zhou · 1 shared paper, 2022 · strength 0.15
- Paper ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. DOI 10.1007/s00259-021-05563-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.